CHANGES OF ACTIVITY INDEX AND TOTAL SEVERITY INDEX IN PATIENTS WITH SYSTEMIC SCLEROSIS AND INTERSTITIAL LUNG DISEASE OVER A 5-YEAR FOLLOW-UP PERIOD
Systemic sclerosis (SS) is a systemic disease, the basis for which is microcirculatory disorders, inflammation, and generalized fibrosis. Interstitial lung disease (ILD) is one of the primary manifestations of SS. Assessment of SS activity and severity is hindered as it is very difficult to differen...
Saved in:
Main Authors: | O. B. Ovsyannikova, L. P. Ananyeva, V. N. Lesnyak, O. A. Koneva, M. N. Starovoitova, O. V. Desinova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2016-07-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2226 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The use of the Scleroderma Clinical Trials Consortium Damage Index in systemic sclerosis
by: L. P. Ananyeva, et al.
Published: (2025-03-01) -
THE IMPORTANCE OF HIGH-RESOLUTION COMPUTED TOMOGRAPHY IN EVALUATING THE EFFICACY OF RITUXIMAB IN PATIENTS WITH INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS
by: O. A. Koneva, et al.
Published: (2018-11-01) -
Relationship between digital ulcers and severity of lung function test in systemic sclerosis over a five-year period
by: O. B. Ovsyannikova, et al.
Published: (2022-09-01) -
Effect of rituximab on the manifestations of activity and pulmonary function in patients with systemic sclerosis: one-year follow-up evaluation
by: L. P. Ananyeva, et al.
Published: (2019-07-01) -
Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01)